Additionally, selective GLUT-1 inhibitors such as rapamycin (mTOR-signaling inhibitor), metformin, and a ketogenic diet may reduce tumor glucose uptake and thereby improve CAR T-cell metabolism in the TME (194). This evidence concerns the gene SLC2A1 and neoplasm.